[Clinical risk factors in coronary disease. The Framingham study].
D000328:Adult; D002784:Cholesterol / Q000096:biosynthesis / Q000097:blood / Q000378:metabolism; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D002914:Chylomicrons / Q000378:metabolism; D003327:Coronary Disease / Q000517:prevention & control*; D004041:Dietary Fats / Q000009:adverse effects; D004705:Endocytosis; D005260:Female; D006801:Humans; D006951:Hyperlipoproteinemias / Q000097:blood; D008055:Lipids / Q000097:blood*; D008074:Lipoproteins / Q000145:classification; D008075:Lipoproteins, HDL / Q000378:metabolism; D008077:Lipoproteins, LDL / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D008247:Lysosomes / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D010743:Phospholipids / Q000097:blood; D012306:Risk
D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D002914:Chylomicrons; D004041:Dietary Fats; D008055:Lipids; D008074:Lipoproteins; D008075:Lipoproteins, HDL; D008077:Lipoproteins, LDL; D010743:Phospholipids; D002784:Cholesterol
Klinische Risikofaktoren bei koronarer Herzkrankheit (KHK). Die Framingham-Studie.